Wolfgang Seibold
InvestorChief Investment Officer & Partner at Hitachi Ventures
About
Wolfgang Seibold, Partner and CFO, structures win‑win‑win deals leveraging corporate market access, sees downturns as chances to birth new champions, and connects startups, corporations and German and European venture associations.
Contact· self-published, not guessed
Invests in
Advanced ManufacturingAI & Machine LearningBiotechClimate TechEnergyFintechHealthtechMobility & Transportation
Investments
Investor
Arsenal BiosciencesBioptimusCure51e6dataGrowInvisixNovoLINCRegrelloRelation TherapeuticsScipher MedicineSophia GeneticsStrikeReadyThea
Per the firm's website.
Colleagues at Hitachi Ventures
Adam Gale
Manager, Fund Administrator at White Star Capital
Annalisa Simons
Head of Administration at Hitachi Ventures
Deepak Mishra
Principal at Hitachi Ventures
Divya Raghavan
Principal at Hitachi Ventures
Edoardo Stazio
Associate at Hitachi Ventures
Galina Sagan
Investment Partner at Hitachi Ventures
Gayathri (G) Radhakrishnan
Partner at Hitachi Ventures
Grace Mathis
Associate at Hitachi Ventures
Frequently asked questions
- Who is Wolfgang Seibold?
- Wolfgang Seibold, Partner and CFO, structures win‑win‑win deals leveraging corporate market access, sees downturns as chances to birth new champions, and connects startups, corporations and German and European venture associations.
- Where does Wolfgang Seibold work?
- Wolfgang Seibold is Chief Investment Officer & Partner at Hitachi Ventures.
- What does Wolfgang Seibold invest in?
- Wolfgang Seibold invests in Advanced Manufacturing, AI & Machine Learning, Biotech, Climate Tech, Energy, Fintech, Healthtech, Mobility & Transportation.
- What companies has Wolfgang Seibold invested in?
- Investments tracked here include Arsenal Biosciences, Bioptimus, Cure51, e6data, Grow, Invisix, NovoLINC, Regrello, Relation Therapeutics, Scipher Medicine, Sophia Genetics, StrikeReady, and 1 more.